Choroid plexus enlargement in secondary progressive MS: phenotype comparison
CP enlargement is a progressive feature of MS, not driven by ventricular expansion. In SPMS, it may reflect ongoing inflammation contributing to tissue damage, supporting its role as a biomarker.
Authors
- Mustapha Bouhrara (ORCID: https://orcid.org/0000-0001-6184-669X)
- Samuel Klistorner (ORCID: https://orcid.org/0000-0001-5761-5178)
- Helmut Butzkueven (ORCID: https://orcid.org/0000-0003-3940-8727)
- Anneke van der Walt (ORCID: https://orcid.org/0000-0002-4278-7003)
- Zhaoyuan Gong (ORCID: https://orcid.org/0000-0001-6488-5424)
- Con Yiannikas (ORCID: https://orcid.org/0000-0002-5372-5879)
- Michael Harry Barnett (ORCID: https://orcid.org/0000-0002-2156-8864)
- Alexander Klistorner (ORCID: https://orcid.org/0000-0003-0361-6399)
- Chenyu Wang (ORCID: https://orcid.org/0000-0001-7135-7662)
- John Parratt
Institutions
- National Institutes of Health (US)
- Royal North Shore Hospital (AU)
- Sydney Hospital (AU)
- Cooperative Trials Group for Neuro-Oncology (AU)
- National Institute on Aging (US)
- Alfred Health (AU)
- Monash University (AU)
- Macquarie University (AU)
Publication Details
- Journal
- Multiple Sclerosis and Related Disorders
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.msard.2025.106832
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00